Molecular subtyping of cancer: current status and moving toward clinical applications
Lan Zhao(First Teaching Hospital of Tianjin University of Traditional Chinese Medicine), Maarten F. Bijlsma(Dutch Cancer Society), Michael K. Ng(Hong Kong Baptist University), Hong Yan(Nanjing Medical University), Victor Lee(University of Ottawa)
Cited by 150
Related Papers
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
|Nature Medicine|2011|1.4k
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial
|The Lancet. Gastroenterology & hepatology|2019|597
Fuzzy Algorithms: With Applications to Image Processing and Pattern Recognition
|Advances in fuzzy systems|1996|496
Interactions of Bacterial Cationic Peptide Antibiotics with Outer and Cytoplasmic Membranes of <i>Pseudomonas aeruginosa</i>
|Antimicrobial Agents and Chemotherapy|2000|344